Lilly Takes Another Leap Into Gene Therapy With Jaguar
Co-leads $139m Fundraising
Following last year's licensing deal with Precision Biosciences and the acquisition of Prevail Therapeutics, Eli Lilly is expanding its gene therapy efforts by backing Jaguar, a start-up staffed by former AveXis bosses.
